{"gene":"GLIS1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2002,"finding":"GLIS1 binds to the Gli-binding site consensus sequence GACCACCCAC as demonstrated by EMSA; contains a C-terminal transactivation domain suppressed by an N-terminal repressor domain; zinc finger region mediates nuclear localization; constitutively active CaMKIV enhances GLIS1-mediated transcriptional activation ~4-fold, possibly via phosphorylation of a co-activator","method":"Electrophoretic mobility shift assay (EMSA), deletion mutant analysis, monohybrid reporter assay, confocal microscopy, CaMKIV co-expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (EMSA, mutagenesis, reporter assay, localization) in a single foundational paper","pmids":["12042312"],"is_preprint":false},{"year":2006,"finding":"GLIS1 expression in NHEK-HPV keratinocytes using a C-terminal deletion mutant (Glis1ΔC) promotes PMA-induced epidermal differentiation, upregulating differentiation-specific genes, suggesting GLIS1 regulates epidermal differentiation gene expression programs","method":"Transgenic expression of Glis1ΔC in keratinocytes, microarray gene expression analysis","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — functional overexpression with transcriptomic readout, single lab","pmids":["16417217"],"is_preprint":false},{"year":2011,"finding":"GLIS1 markedly enhances iPSC reprogramming efficiency from mouse and human fibroblasts when co-expressed with OSK (Oct3/4, Sox2, Klf4); DNA microarray analysis shows GLIS1 activates pro-reprogramming pathways including Myc, Nanog, Lin28, Wnt, Essrb, and mesenchymal-epithelial transition; GLIS1 is enriched in unfertilized oocytes and 1-cell stage embryos","method":"Retroviral transduction of GLIS1 + OSK into fibroblasts, iPSC generation assay, DNA microarray, germline chimera formation","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — replicated across mouse and human systems, multiple pathway readouts, widely cited foundational study","pmids":["21654807"],"is_preprint":false},{"year":2014,"finding":"GLIS1 cooperates with CUX1 to stimulate TCF/β-catenin transcriptional activity and enhance cancer cell migration and invasion, linking GLIS1 to autocrine Wnt/β-catenin pathway activation","method":"Co-expression experiments, TCF/β-catenin luciferase reporter assay, cell migration and invasion assays","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assay plus functional cellular assays, single lab","pmids":["25217618"],"is_preprint":false},{"year":2019,"finding":"GLIS1 knockdown by morpholinos in zebrafish causes atrioventricular regurgitation in developing hearts; Glis1 is expressed in nuclei of endothelial and interstitial cells of mitral valves during embryonic development, establishing a role in cardiac valve development","method":"Morpholino knockdown in zebrafish, immunohistochemistry in mouse embryonic heart","journal":"Circulation. Genomic and precision medicine","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function in vivo model with defined cardiac phenotype, corroborated by localization data","pmids":["31112420"],"is_preprint":false},{"year":2019,"finding":"GLIS1 is identified as a mesenchymal key transcription factor controlled by dynamic super-enhancers; overexpression of GLIS1 in multipotent bone marrow stromal ST2 cells inhibits lineage commitment toward both adipocytes and osteoblasts, regulating differentiation-induced genes","method":"Time-series transcriptomics (RNA-seq), ATAC-seq, super-enhancer mapping, GLIS1 overexpression with differentiation assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — multi-omic approach with functional overexpression validation, single lab","pmids":["30544251"],"is_preprint":false},{"year":2019,"finding":"GLIS1, together with Jdp2, Jhdm1b, Mkk6, Nanog, Essrb, and Sall4 (7F), reprograms MEFs to chimera-competent iPSCs via cooperative dynamic chromatin opening and closing at transcription factor network loci, as revealed by RNA-seq and ATAC-seq dropout experiments","method":"7-factor reprogramming of MEFs, RNA-seq, ATAC-seq, dropout experiments","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — multi-omic epistasis approach in reprogramming, single lab","pmids":["31216469"],"is_preprint":false},{"year":2020,"finding":"GLIS1 directly binds to and opens chromatin at glycolytic gene loci while closing chromatin at somatic gene loci during early reprogramming; increased glycolytic flux elevates cellular acetyl-CoA and lactate, enhancing H3K27Ac and H3K18la at pluripotency gene loci, establishing an epigenome-metabolome-epigenome cascade","method":"ATAC-seq, ChIP-seq, metabolomics, chromatin accessibility assays, histone modification profiling","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal genome-wide methods plus metabolic measurements revealing direct chromatin binding and downstream epigenetic effects","pmids":["32839595"],"is_preprint":false},{"year":2020,"finding":"GLIS1 promotes breast cancer cell motility and invasion via transcriptional activation of WNT5A; WNT5A knockdown reverses GLIS1-mediated cell motility enhancement; GLIS1 expression is induced under hypoxia by HIF-2α cooperating with AP-1 members","method":"siRNA knockdown, stable overexpression, wound-healing and invasion assays, whole transcriptome analysis, WNT5A siRNA rescue experiment","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis via WNT5A knockdown rescue, multiple functional assays, single lab","pmids":["32047936"],"is_preprint":false},{"year":2020,"finding":"miR-1-3p directly targets GLIS1 mRNA as confirmed by dual-luciferase reporter assay; GLIS1 overexpression neutralizes miR-1-3p-mediated suppression of breast cancer cell viability, invasion, migration, and EMT","method":"Dual-luciferase reporter assay, gain-of-function overexpression rescue experiments, in vitro and in vivo tumor assays","journal":"Cancer gene therapy","confidence":"Medium","confidence_rationale":"Tier 2 — luciferase reporter confirms direct targeting, functional rescue experiment, single lab","pmids":["33154575"],"is_preprint":false},{"year":2021,"finding":"GLIS1 deficiency in mice leads to progressive degeneration of the trabecular meshwork, impaired aqueous humor drainage, and chronically elevated intraocular pressure; transcriptome and cistrome analyses identify glaucoma- and extracellular matrix-associated genes as direct GLIS1 transcriptional targets in trabecular meshwork","method":"GLIS1 knockout mice, MRI, histopathology, intraocular pressure measurement, transcriptome and cistrome (ChIP-seq) analyses","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo KO with defined physiological phenotype plus direct cistrome identification of target genes, multiple methods","pmids":["34385434"],"is_preprint":false},{"year":2023,"finding":"GLIS1 in CD8+ T cells transcriptionally regulates the SGK1-STAT3-PD1 pathway via chromatin immunoprecipitation-confirmed binding, maintaining high PD1 surface expression and promoting T cell exhaustion in hepatocellular carcinoma","method":"ChIP-seq, RNA-seq, GLIS1 knockdown in CD8+ T cells, in vivo mouse models, flow cytometry","journal":"Journal for immunotherapy of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP confirms direct binding to SGK1 locus, in vivo functional validation, single lab","pmids":["36787938"],"is_preprint":false},{"year":2023,"finding":"GLIS1 interacts with PGC1-α to maintain mitochondrial quality control (biogenesis, fission, mitophagy) in kidney aging; siGLIS1 inhibits PGC1-α transcription and disrupts mitochondria-protective functions; GLIS1 overexpression inhibits extracellular matrix accumulation and renal fibrosis","method":"Co-immunoprecipitation/protein interaction, siRNA knockdown, GLIS1 overexpression in vivo and in vitro, mitochondrial functional assays","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 — protein interaction with PGC1-α supported by functional phenotype in vivo and in vitro, single lab","pmids":["37852548"],"is_preprint":false},{"year":2023,"finding":"GLIS1 promotes transcription of COMP and ITGA11 by directly binding to their promoter regions, thereby enhancing cervical cancer cell migration, invasion, and EMT; knockdown of COMP or ITGA11 reverses GLIS1-driven malignant phenotype","method":"ChIP assay (GLIS1 binding to COMP and ITGA11 promoters), siRNA knockdown rescue, migration and invasion assays","journal":"Reproductive sciences","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP confirms direct promoter binding, epistasis via downstream gene knockdown, single lab","pmids":["38157104"],"is_preprint":false},{"year":2024,"finding":"GLIS1 inhibits histone lactylation by directly interacting with lactyltransferase KAT5 (predicted by AlphaFold2/AutoDock and supported by in vitro binding reduction), reducing KAT5-histone H3 interaction and thus protecting against RTEC cellular senescence and renal fibrosis in diabetic kidney disease","method":"AlphaFold2/AutoDock structural prediction, co-immunoprecipitation (KAT5-histone H3 interaction), GLIS1 CKO and overexpression mouse models, lactylation inhibitor/enhancer pharmacology","journal":"Life sciences","confidence":"Medium","confidence_rationale":"Tier 3 — binding predicted computationally with supporting functional co-IP data and in vivo rescue, single lab","pmids":["39643036"],"is_preprint":false},{"year":2024,"finding":"GLIS1 mRNA is subject to m6A modification regulated by METTL3 (writer) and YTHDF1 (reader promoting translation); decreased METTL3/YTHDF1 in aged kidneys reduces GLIS1 protein translation, leading to metabolic shift from fatty acid oxidation to glycolysis, cell senescence, and renal fibrosis","method":"m6A epitranscriptomic microarray, RNA immunoprecipitation (RIP), ribosomal immunoprecipitation, ChIP, luciferase reporter assays, METTL3/YTHDF1 silencing","journal":"BMC biology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (RIP, ribosomal IP, reporter assay) identifying m6A writer/reader for GLIS1, single lab","pmids":["39736678"],"is_preprint":false}],"current_model":"GLIS1 is a nuclear Krüppel-like zinc finger transcription factor that binds the consensus sequence GACCACCCAC via its zinc finger domain; it contains opposing N-terminal repressor and C-terminal activator domains, and acts as a pioneer-like factor that directly opens chromatin at glycolytic and pluripotency gene loci while closing somatic gene loci, driving an epigenome-metabolome-epigenome cascade (via increased acetyl-CoA/lactate → H3K27Ac/H3K18la) to promote iPSC reprogramming; it also directly regulates trabecular meshwork ECM genes to control intraocular pressure, drives T cell exhaustion via SGK1-STAT3-PD1 transcriptional regulation, maintains mitochondrial quality control through interaction with PGC1-α, suppresses histone lactylation by interfering with KAT5, and its own translation is post-transcriptionally regulated by METTL3/YTHDF1-mediated m6A modification."},"narrative":{"teleology":[{"year":2002,"claim":"Establishing GLIS1 as a zinc finger transcription factor with defined DNA-binding specificity and modular activation/repression domains answered the foundational question of what type of protein GLIS1 encodes and how its activity is structured.","evidence":"EMSA, deletion mutant analysis, monohybrid reporter assays, and confocal microscopy in mammalian cells","pmids":["12042312"],"confidence":"High","gaps":["Endogenous target genes unknown","CaMKIV enhancement mechanism (direct phosphorylation vs. co-activator modification) unresolved","No in vivo loss-of-function data"]},{"year":2006,"claim":"Demonstrating that a GLIS1 deletion mutant alters keratinocyte differentiation gene programs provided the first evidence that GLIS1 functions as a cell-fate regulator beyond a generic transcription factor.","evidence":"Overexpression of Glis1ΔC in NHEK-HPV keratinocytes with microarray readout","pmids":["16417217"],"confidence":"Medium","gaps":["Used C-terminal deletion mutant rather than wild-type, complicating interpretation","No loss-of-function data in keratinocytes","Direct target genes not identified by ChIP"]},{"year":2011,"claim":"Showing that GLIS1 co-expression with OSK dramatically enhances iPSC reprogramming in both mouse and human fibroblasts revealed GLIS1 as a potent pluripotency-enabling factor, consistent with its enrichment in oocytes and zygotes.","evidence":"Retroviral transduction of GLIS1+OSK into fibroblasts, iPSC colony counting, DNA microarray, germline chimera formation","pmids":["21654807"],"confidence":"High","gaps":["Mechanism of chromatin remodeling by GLIS1 during reprogramming unknown at this stage","Direct versus indirect activation of Myc/Nanog/Wnt pathways unresolved"]},{"year":2019,"claim":"Three contemporaneous studies expanded GLIS1's functional scope: cooperative chromatin opening in a 7-factor reprogramming system, regulation of mesenchymal lineage commitment via super-enhancers, and requirement for cardiac valve development in zebrafish, collectively establishing GLIS1 as a broadly acting chromatin and developmental regulator.","evidence":"7-factor reprogramming with ATAC-seq/RNA-seq dropout (MEFs); super-enhancer mapping plus overexpression in ST2 cells; morpholino knockdown in zebrafish with IHC in mouse embryonic heart","pmids":["31216469","30544251","31112420"],"confidence":"Medium","gaps":["Zebrafish morpholino phenotype not confirmed by genetic knockout","Direct GLIS1 binding sites in mesenchymal or cardiac valve genes not mapped","Relative contribution of GLIS1 versus other factors in 7F system unclear"]},{"year":2020,"claim":"ChIP-seq and ATAC-seq demonstrated that GLIS1 directly binds and opens glycolytic gene chromatin while closing somatic loci, and metabolomic profiling showed the resulting metabolic shift feeds back via acetyl-CoA and lactate to install activating histone marks at pluripotency loci — resolving the mechanistic basis of GLIS1's reprogramming activity as an epigenome–metabolome–epigenome cascade.","evidence":"ATAC-seq, ChIP-seq, metabolomics, histone modification profiling during GLIS1-driven reprogramming","pmids":["32839595"],"confidence":"High","gaps":["Whether GLIS1 acts as a true pioneer factor (binds closed nucleosomal DNA) versus a facilitator of existing accessible sites not formally tested","Structural basis of GLIS1–chromatin interaction unknown"]},{"year":2020,"claim":"Identification of WNT5A as a direct transcriptional target mediating GLIS1-driven breast cancer motility, with GLIS1 itself induced by HIF-2α/AP-1 under hypoxia, placed GLIS1 in a hypoxia–Wnt signaling axis promoting cancer invasion; separately, miR-1-3p was confirmed to directly target GLIS1 mRNA, establishing post-transcriptional regulation.","evidence":"siRNA knockdown rescue of WNT5A, transcriptome analysis, luciferase reporter for miR-1-3p targeting of GLIS1 3′UTR, in vivo tumor assays","pmids":["32047936","33154575"],"confidence":"Medium","gaps":["Direct ChIP confirmation of GLIS1 binding at WNT5A promoter not shown","Relevance to primary human tumors versus cell line systems uncertain","Cooperation with CUX1 at Wnt loci (from 2014 study) not integrated"]},{"year":2021,"claim":"Genetic knockout of GLIS1 in mice caused progressive trabecular meshwork degeneration and chronically elevated intraocular pressure, while cistrome analysis identified ECM and glaucoma-associated genes as direct targets, providing definitive in vivo evidence for GLIS1 in intraocular pressure regulation and glaucoma pathogenesis.","evidence":"GLIS1 KO mice, MRI, histopathology, IOP measurement, transcriptome and ChIP-seq in trabecular meshwork","pmids":["34385434"],"confidence":"High","gaps":["Human genetic validation (GLIS1 mutations in glaucoma patients) not established","Downstream effector mechanisms (specific ECM components) not functionally validated individually"]},{"year":2023,"claim":"Three studies revealed new GLIS1 transcriptional programs in distinct cellular contexts: direct activation of SGK1–STAT3–PD1 axis driving CD8+ T cell exhaustion, interaction with PGC1-α maintaining mitochondrial quality control in aging kidneys, and direct activation of COMP/ITGA11 promoting cervical cancer EMT — demonstrating GLIS1 as a context-dependent transcriptional regulator of immunity, mitochondrial homeostasis, and tumor invasion.","evidence":"ChIP-seq/RNA-seq in CD8+ T cells with in vivo tumor models; co-IP of GLIS1–PGC1-α with siRNA and overexpression in kidney models; ChIP at COMP/ITGA11 promoters with siRNA rescue in cervical cancer cells","pmids":["36787938","37852548","38157104"],"confidence":"Medium","gaps":["PGC1-α interaction domain on GLIS1 not mapped","Whether GLIS1-driven T cell exhaustion is reversible therapeutically unknown","Single-lab findings for each context await independent replication"]},{"year":2024,"claim":"Two studies uncovered regulatory layers controlling GLIS1 function: GLIS1 physically interferes with KAT5 lactyltransferase–histone H3 interaction to suppress histone lactylation and cellular senescence, while METTL3/YTHDF1-mediated m6A modification of GLIS1 mRNA controls its translational efficiency in aging kidneys — establishing both a non-transcriptional effector mechanism and an epitranscriptomic input regulating GLIS1 protein levels.","evidence":"AlphaFold2/AutoDock prediction with co-IP validation and GLIS1 CKO/overexpression mouse models for KAT5; m6A-seq, RIP, ribosomal IP, luciferase reporters, and METTL3/YTHDF1 silencing for m6A regulation","pmids":["39643036","39736678"],"confidence":"Medium","gaps":["GLIS1–KAT5 interaction relies on computational prediction without crystallographic validation","Whether m6A regulation of GLIS1 operates beyond kidney tissue is unknown","Single-lab findings for both mechanisms"]},{"year":null,"claim":"Major open questions include whether GLIS1 functions as a bona fide pioneer factor capable of binding nucleosomal DNA, the structural basis of its interactions with chromatin and protein partners (PGC1-α, KAT5), whether GLIS1 variants contribute to human glaucoma or other Mendelian diseases, and how its diverse context-dependent transcriptional programs are specified.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural data for GLIS1 or its complexes","Pioneer factor status not formally tested with nucleosome binding assays","Human genetic studies linking GLIS1 mutations to disease are absent from the literature"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,7,10,11,13]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,7,10,11,13]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,4,7]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,2,7,10,11]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,5]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[10,13]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[11]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[7]}],"complexes":[],"partners":["PGC1A","KAT5","CUX1","METTL3","YTHDF1"],"other_free_text":[]},"mechanistic_narrative":"GLIS1 is a Krüppel-like zinc finger transcription factor that functions as a pioneer-like chromatin remodeler and transcriptional regulator across diverse biological contexts including pluripotency reprogramming, tissue homeostasis, and immune cell fate. GLIS1 binds the consensus sequence GACCACCCAC via its zinc finger domain and contains an N-terminal repressor domain and a C-terminal transactivation domain modulated by CaMKIV signaling; during iPSC reprogramming, it directly opens chromatin at glycolytic and pluripotency gene loci while closing somatic loci, driving an epigenome–metabolome–epigenome cascade in which increased acetyl-CoA and lactate enhance H3K27Ac and H3K18la at pluripotency genes [PMID:12042312, PMID:21654807, PMID:32839595]. In vivo, GLIS1 deficiency causes progressive trabecular meshwork degeneration and elevated intraocular pressure through loss of direct transcriptional control over extracellular matrix genes, establishing GLIS1 as a glaucoma-associated gene [PMID:34385434]. GLIS1 additionally drives T cell exhaustion by transcriptionally activating the SGK1–STAT3–PD1 axis, interacts with PGC1-α to maintain mitochondrial quality control in kidney aging, and interferes with KAT5-mediated histone lactylation to protect against renal tubular epithelial cell senescence, while its own translation is regulated by METTL3/YTHDF1-dependent m6A modification [PMID:36787938, PMID:37852548, PMID:39643036, PMID:39736678]."},"prefetch_data":{"uniprot":{"accession":"Q8NBF1","full_name":"Zinc finger protein GLIS1","aliases":["GLI-similar 1"],"length_aa":620,"mass_kda":66.0,"function":"Acts both as a repressor and an activator of transcription (PubMed:21654807). Binds to the consensus sequence 5'-GACCACCCAC-3' (By similarity). By controlling the expression of genes involved in cell differentiation inhibits the lineage commitment of multipotent cells (PubMed:21654807). Prevents, for instance, the differentiation of multipotent mesenchymal cells into adipocyte and osteoblast (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8NBF1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GLIS1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GLIS1","total_profiled":1310},"omim":[{"mim_id":"610378","title":"GLIS FAMILY ZINC FINGER PROTEIN 1; GLIS1","url":"https://www.omim.org/entry/610378"},{"mim_id":"610192","title":"GLIS FAMILY ZINC FINGER PROTEIN 3; GLIS3","url":"https://www.omim.org/entry/610192"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"prostate","ntpm":7.7},{"tissue":"seminal vesicle","ntpm":7.0}],"url":"https://www.proteinatlas.org/search/GLIS1"},"hgnc":{"alias_symbol":["FLJ36155"],"prev_symbol":[]},"alphafold":{"accession":"Q8NBF1","domains":[{"cath_id":"3.30.160.60","chopping":"194-260","consensus_level":"medium","plddt":84.9499,"start":194,"end":260},{"cath_id":"3.30.160","chopping":"321-358","consensus_level":"medium","plddt":80.9092,"start":321,"end":358}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8NBF1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NBF1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NBF1-F1-predicted_aligned_error_v6.png","plddt_mean":52.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GLIS1","jax_strain_url":"https://www.jax.org/strain/search?query=GLIS1"},"sequence":{"accession":"Q8NBF1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8NBF1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8NBF1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8NBF1"}},"corpus_meta":[{"pmid":"21654807","id":"PMC_21654807","title":"Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21654807","citation_count":309,"is_preprint":false},{"pmid":"32839595","id":"PMC_32839595","title":"Glis1 facilitates induction of pluripotency via an epigenome-metabolome-epigenome signalling cascade.","date":"2020","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32839595","citation_count":252,"is_preprint":false},{"pmid":"29779043","id":"PMC_29779043","title":"GLIS1-3 transcription factors: critical roles in the regulation of multiple physiological processes and diseases.","date":"2018","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/29779043","citation_count":74,"is_preprint":false},{"pmid":"12042312","id":"PMC_12042312","title":"Identification of Glis1, a novel Gli-related, Kruppel-like zinc finger protein containing transactivation and repressor functions.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12042312","citation_count":63,"is_preprint":false},{"pmid":"31216469","id":"PMC_31216469","title":"Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Jdp2-Jhdm1b-Mkk6-Glis1-Nanog-Essrb-Sall4.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31216469","citation_count":43,"is_preprint":false},{"pmid":"25217618","id":"PMC_25217618","title":"Autocrine Activation of the Wnt/β-Catenin Pathway by CUX1 and GLIS1 in Breast Cancers.","date":"2014","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/25217618","citation_count":40,"is_preprint":false},{"pmid":"29057252","id":"PMC_29057252","title":"GLIS1-3: emerging roles in reprogramming, stem and progenitor cell differentiation and maintenance.","date":"2017","source":"Stem cell investigation","url":"https://pubmed.ncbi.nlm.nih.gov/29057252","citation_count":40,"is_preprint":false},{"pmid":"33154575","id":"PMC_33154575","title":"Elevating microRNA-1-3p shuttled by cancer-associated fibroblasts-derived extracellular vesicles suppresses breast cancer progression and metastasis by inhibiting GLIS1.","date":"2020","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33154575","citation_count":35,"is_preprint":false},{"pmid":"31112420","id":"PMC_31112420","title":"Genome-Wide Association Study-Driven Gene-Set Analyses, Genetic, and Functional Follow-Up Suggest GLIS1 as a Susceptibility Gene for Mitral Valve Prolapse.","date":"2019","source":"Circulation. Genomic and precision medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31112420","citation_count":31,"is_preprint":false},{"pmid":"34385434","id":"PMC_34385434","title":"GLIS1 regulates trabecular meshwork function and intraocular pressure and is associated with glaucoma in humans.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34385434","citation_count":28,"is_preprint":false},{"pmid":"39643036","id":"PMC_39643036","title":"Glis1 inhibits RTEC cellular senescence and renal fibrosis by downregulating histone lactylation in DKD.","date":"2024","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39643036","citation_count":28,"is_preprint":false},{"pmid":"35216340","id":"PMC_35216340","title":"GLIS1 in Cancer-Associated Fibroblasts Regulates the Migration and Invasion of Ovarian Cancer Cells.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35216340","citation_count":26,"is_preprint":false},{"pmid":"16417217","id":"PMC_16417217","title":"Regulatory role for Krüppel-like zinc-finger protein Gli-similar 1 (Glis1) in PMA-treated and psoriatic epidermis.","date":"2006","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/16417217","citation_count":23,"is_preprint":false},{"pmid":"37852548","id":"PMC_37852548","title":"GLIS1 alleviates cell senescence and renal fibrosis through PGC1-α mediated mitochondrial quality control in kidney aging.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37852548","citation_count":22,"is_preprint":false},{"pmid":"34132943","id":"PMC_34132943","title":"GLIS1, a potential candidate gene affect fat deposition in sheep tail.","date":"2021","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/34132943","citation_count":21,"is_preprint":false},{"pmid":"36787938","id":"PMC_36787938","title":"GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway.","date":"2023","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36787938","citation_count":18,"is_preprint":false},{"pmid":"30544251","id":"PMC_30544251","title":"Temporal enhancer profiling of parallel lineages identifies AHR and GLIS1 as regulators of mesenchymal multipotency.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30544251","citation_count":18,"is_preprint":false},{"pmid":"32047936","id":"PMC_32047936","title":"GLIS1, a novel hypoxia-inducible transcription factor, promotes breast cancer cell motility via activation of WNT5A.","date":"2020","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/32047936","citation_count":17,"is_preprint":false},{"pmid":"22759478","id":"PMC_22759478","title":"GLIS1 rs797906: an increased risk factor for late-onset Parkinson's disease in the Han Chinese population.","date":"2012","source":"European neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22759478","citation_count":12,"is_preprint":false},{"pmid":"32699115","id":"PMC_32699115","title":"Gene of the month: GLIS1-3.","date":"2020","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32699115","citation_count":11,"is_preprint":false},{"pmid":"35681527","id":"PMC_35681527","title":"GLIS1-3: Links to Primary Cilium, Reprogramming, Stem Cell Renewal, and Disease.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35681527","citation_count":10,"is_preprint":false},{"pmid":"39736678","id":"PMC_39736678","title":"N6-methyladenosine regulates metabolic remodeling in kidney aging through transcriptional regulator GLIS1.","date":"2024","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/39736678","citation_count":4,"is_preprint":false},{"pmid":"38003209","id":"PMC_38003209","title":"The Role of BDNF, YBX1, CENPF, ZSCAN4, TEAD4, GLIS1 and USF1 in the Activation of the Embryonic Genome in Bovine Embryos.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38003209","citation_count":4,"is_preprint":false},{"pmid":"36406265","id":"PMC_36406265","title":"Glis1 and oxaloacetate in nucleus pulposus stromal cell somatic reprogramming and survival.","date":"2022","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/36406265","citation_count":4,"is_preprint":false},{"pmid":"37978100","id":"PMC_37978100","title":"An Insight into the Role of GLIS1 in Embryonic Development, iPSC Generation, and Cancer.","date":"2024","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/37978100","citation_count":2,"is_preprint":false},{"pmid":"34528219","id":"PMC_34528219","title":"Identification of Optimal Expression Parameters and Purification of a Codon-Optimized Human GLIS1 Transcription Factor from Escherichia coli.","date":"2021","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/34528219","citation_count":2,"is_preprint":false},{"pmid":"38157104","id":"PMC_38157104","title":"Effect of GLIS1 on the Lymph Node Metastasis of Cervical Squamous Carcinoma Based on Transcriptome Analysis.","date":"2023","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/38157104","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13549,"output_tokens":3752,"usd":0.048463},"stage2":{"model":"claude-opus-4-6","input_tokens":7219,"output_tokens":3128,"usd":0.171442},"total_usd":0.219905,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"GLIS1 binds to the Gli-binding site consensus sequence GACCACCCAC as demonstrated by EMSA; contains a C-terminal transactivation domain suppressed by an N-terminal repressor domain; zinc finger region mediates nuclear localization; constitutively active CaMKIV enhances GLIS1-mediated transcriptional activation ~4-fold, possibly via phosphorylation of a co-activator\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA), deletion mutant analysis, monohybrid reporter assay, confocal microscopy, CaMKIV co-expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (EMSA, mutagenesis, reporter assay, localization) in a single foundational paper\",\n      \"pmids\": [\"12042312\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GLIS1 expression in NHEK-HPV keratinocytes using a C-terminal deletion mutant (Glis1ΔC) promotes PMA-induced epidermal differentiation, upregulating differentiation-specific genes, suggesting GLIS1 regulates epidermal differentiation gene expression programs\",\n      \"method\": \"Transgenic expression of Glis1ΔC in keratinocytes, microarray gene expression analysis\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional overexpression with transcriptomic readout, single lab\",\n      \"pmids\": [\"16417217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GLIS1 markedly enhances iPSC reprogramming efficiency from mouse and human fibroblasts when co-expressed with OSK (Oct3/4, Sox2, Klf4); DNA microarray analysis shows GLIS1 activates pro-reprogramming pathways including Myc, Nanog, Lin28, Wnt, Essrb, and mesenchymal-epithelial transition; GLIS1 is enriched in unfertilized oocytes and 1-cell stage embryos\",\n      \"method\": \"Retroviral transduction of GLIS1 + OSK into fibroblasts, iPSC generation assay, DNA microarray, germline chimera formation\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — replicated across mouse and human systems, multiple pathway readouts, widely cited foundational study\",\n      \"pmids\": [\"21654807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GLIS1 cooperates with CUX1 to stimulate TCF/β-catenin transcriptional activity and enhance cancer cell migration and invasion, linking GLIS1 to autocrine Wnt/β-catenin pathway activation\",\n      \"method\": \"Co-expression experiments, TCF/β-catenin luciferase reporter assay, cell migration and invasion assays\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay plus functional cellular assays, single lab\",\n      \"pmids\": [\"25217618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GLIS1 knockdown by morpholinos in zebrafish causes atrioventricular regurgitation in developing hearts; Glis1 is expressed in nuclei of endothelial and interstitial cells of mitral valves during embryonic development, establishing a role in cardiac valve development\",\n      \"method\": \"Morpholino knockdown in zebrafish, immunohistochemistry in mouse embryonic heart\",\n      \"journal\": \"Circulation. Genomic and precision medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function in vivo model with defined cardiac phenotype, corroborated by localization data\",\n      \"pmids\": [\"31112420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GLIS1 is identified as a mesenchymal key transcription factor controlled by dynamic super-enhancers; overexpression of GLIS1 in multipotent bone marrow stromal ST2 cells inhibits lineage commitment toward both adipocytes and osteoblasts, regulating differentiation-induced genes\",\n      \"method\": \"Time-series transcriptomics (RNA-seq), ATAC-seq, super-enhancer mapping, GLIS1 overexpression with differentiation assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multi-omic approach with functional overexpression validation, single lab\",\n      \"pmids\": [\"30544251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GLIS1, together with Jdp2, Jhdm1b, Mkk6, Nanog, Essrb, and Sall4 (7F), reprograms MEFs to chimera-competent iPSCs via cooperative dynamic chromatin opening and closing at transcription factor network loci, as revealed by RNA-seq and ATAC-seq dropout experiments\",\n      \"method\": \"7-factor reprogramming of MEFs, RNA-seq, ATAC-seq, dropout experiments\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multi-omic epistasis approach in reprogramming, single lab\",\n      \"pmids\": [\"31216469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GLIS1 directly binds to and opens chromatin at glycolytic gene loci while closing chromatin at somatic gene loci during early reprogramming; increased glycolytic flux elevates cellular acetyl-CoA and lactate, enhancing H3K27Ac and H3K18la at pluripotency gene loci, establishing an epigenome-metabolome-epigenome cascade\",\n      \"method\": \"ATAC-seq, ChIP-seq, metabolomics, chromatin accessibility assays, histone modification profiling\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal genome-wide methods plus metabolic measurements revealing direct chromatin binding and downstream epigenetic effects\",\n      \"pmids\": [\"32839595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GLIS1 promotes breast cancer cell motility and invasion via transcriptional activation of WNT5A; WNT5A knockdown reverses GLIS1-mediated cell motility enhancement; GLIS1 expression is induced under hypoxia by HIF-2α cooperating with AP-1 members\",\n      \"method\": \"siRNA knockdown, stable overexpression, wound-healing and invasion assays, whole transcriptome analysis, WNT5A siRNA rescue experiment\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via WNT5A knockdown rescue, multiple functional assays, single lab\",\n      \"pmids\": [\"32047936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"miR-1-3p directly targets GLIS1 mRNA as confirmed by dual-luciferase reporter assay; GLIS1 overexpression neutralizes miR-1-3p-mediated suppression of breast cancer cell viability, invasion, migration, and EMT\",\n      \"method\": \"Dual-luciferase reporter assay, gain-of-function overexpression rescue experiments, in vitro and in vivo tumor assays\",\n      \"journal\": \"Cancer gene therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — luciferase reporter confirms direct targeting, functional rescue experiment, single lab\",\n      \"pmids\": [\"33154575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GLIS1 deficiency in mice leads to progressive degeneration of the trabecular meshwork, impaired aqueous humor drainage, and chronically elevated intraocular pressure; transcriptome and cistrome analyses identify glaucoma- and extracellular matrix-associated genes as direct GLIS1 transcriptional targets in trabecular meshwork\",\n      \"method\": \"GLIS1 knockout mice, MRI, histopathology, intraocular pressure measurement, transcriptome and cistrome (ChIP-seq) analyses\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo KO with defined physiological phenotype plus direct cistrome identification of target genes, multiple methods\",\n      \"pmids\": [\"34385434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GLIS1 in CD8+ T cells transcriptionally regulates the SGK1-STAT3-PD1 pathway via chromatin immunoprecipitation-confirmed binding, maintaining high PD1 surface expression and promoting T cell exhaustion in hepatocellular carcinoma\",\n      \"method\": \"ChIP-seq, RNA-seq, GLIS1 knockdown in CD8+ T cells, in vivo mouse models, flow cytometry\",\n      \"journal\": \"Journal for immunotherapy of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirms direct binding to SGK1 locus, in vivo functional validation, single lab\",\n      \"pmids\": [\"36787938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GLIS1 interacts with PGC1-α to maintain mitochondrial quality control (biogenesis, fission, mitophagy) in kidney aging; siGLIS1 inhibits PGC1-α transcription and disrupts mitochondria-protective functions; GLIS1 overexpression inhibits extracellular matrix accumulation and renal fibrosis\",\n      \"method\": \"Co-immunoprecipitation/protein interaction, siRNA knockdown, GLIS1 overexpression in vivo and in vitro, mitochondrial functional assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — protein interaction with PGC1-α supported by functional phenotype in vivo and in vitro, single lab\",\n      \"pmids\": [\"37852548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GLIS1 promotes transcription of COMP and ITGA11 by directly binding to their promoter regions, thereby enhancing cervical cancer cell migration, invasion, and EMT; knockdown of COMP or ITGA11 reverses GLIS1-driven malignant phenotype\",\n      \"method\": \"ChIP assay (GLIS1 binding to COMP and ITGA11 promoters), siRNA knockdown rescue, migration and invasion assays\",\n      \"journal\": \"Reproductive sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirms direct promoter binding, epistasis via downstream gene knockdown, single lab\",\n      \"pmids\": [\"38157104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GLIS1 inhibits histone lactylation by directly interacting with lactyltransferase KAT5 (predicted by AlphaFold2/AutoDock and supported by in vitro binding reduction), reducing KAT5-histone H3 interaction and thus protecting against RTEC cellular senescence and renal fibrosis in diabetic kidney disease\",\n      \"method\": \"AlphaFold2/AutoDock structural prediction, co-immunoprecipitation (KAT5-histone H3 interaction), GLIS1 CKO and overexpression mouse models, lactylation inhibitor/enhancer pharmacology\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — binding predicted computationally with supporting functional co-IP data and in vivo rescue, single lab\",\n      \"pmids\": [\"39643036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GLIS1 mRNA is subject to m6A modification regulated by METTL3 (writer) and YTHDF1 (reader promoting translation); decreased METTL3/YTHDF1 in aged kidneys reduces GLIS1 protein translation, leading to metabolic shift from fatty acid oxidation to glycolysis, cell senescence, and renal fibrosis\",\n      \"method\": \"m6A epitranscriptomic microarray, RNA immunoprecipitation (RIP), ribosomal immunoprecipitation, ChIP, luciferase reporter assays, METTL3/YTHDF1 silencing\",\n      \"journal\": \"BMC biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (RIP, ribosomal IP, reporter assay) identifying m6A writer/reader for GLIS1, single lab\",\n      \"pmids\": [\"39736678\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GLIS1 is a nuclear Krüppel-like zinc finger transcription factor that binds the consensus sequence GACCACCCAC via its zinc finger domain; it contains opposing N-terminal repressor and C-terminal activator domains, and acts as a pioneer-like factor that directly opens chromatin at glycolytic and pluripotency gene loci while closing somatic gene loci, driving an epigenome-metabolome-epigenome cascade (via increased acetyl-CoA/lactate → H3K27Ac/H3K18la) to promote iPSC reprogramming; it also directly regulates trabecular meshwork ECM genes to control intraocular pressure, drives T cell exhaustion via SGK1-STAT3-PD1 transcriptional regulation, maintains mitochondrial quality control through interaction with PGC1-α, suppresses histone lactylation by interfering with KAT5, and its own translation is post-transcriptionally regulated by METTL3/YTHDF1-mediated m6A modification.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GLIS1 is a Krüppel-like zinc finger transcription factor that functions as a pioneer-like chromatin remodeler and transcriptional regulator across diverse biological contexts including pluripotency reprogramming, tissue homeostasis, and immune cell fate. GLIS1 binds the consensus sequence GACCACCCAC via its zinc finger domain and contains an N-terminal repressor domain and a C-terminal transactivation domain modulated by CaMKIV signaling; during iPSC reprogramming, it directly opens chromatin at glycolytic and pluripotency gene loci while closing somatic loci, driving an epigenome–metabolome–epigenome cascade in which increased acetyl-CoA and lactate enhance H3K27Ac and H3K18la at pluripotency genes [PMID:12042312, PMID:21654807, PMID:32839595]. In vivo, GLIS1 deficiency causes progressive trabecular meshwork degeneration and elevated intraocular pressure through loss of direct transcriptional control over extracellular matrix genes, establishing GLIS1 as a glaucoma-associated gene [PMID:34385434]. GLIS1 additionally drives T cell exhaustion by transcriptionally activating the SGK1–STAT3–PD1 axis, interacts with PGC1-α to maintain mitochondrial quality control in kidney aging, and interferes with KAT5-mediated histone lactylation to protect against renal tubular epithelial cell senescence, while its own translation is regulated by METTL3/YTHDF1-dependent m6A modification [PMID:36787938, PMID:37852548, PMID:39643036, PMID:39736678].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing GLIS1 as a zinc finger transcription factor with defined DNA-binding specificity and modular activation/repression domains answered the foundational question of what type of protein GLIS1 encodes and how its activity is structured.\",\n      \"evidence\": \"EMSA, deletion mutant analysis, monohybrid reporter assays, and confocal microscopy in mammalian cells\",\n      \"pmids\": [\"12042312\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous target genes unknown\", \"CaMKIV enhancement mechanism (direct phosphorylation vs. co-activator modification) unresolved\", \"No in vivo loss-of-function data\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating that a GLIS1 deletion mutant alters keratinocyte differentiation gene programs provided the first evidence that GLIS1 functions as a cell-fate regulator beyond a generic transcription factor.\",\n      \"evidence\": \"Overexpression of Glis1ΔC in NHEK-HPV keratinocytes with microarray readout\",\n      \"pmids\": [\"16417217\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Used C-terminal deletion mutant rather than wild-type, complicating interpretation\", \"No loss-of-function data in keratinocytes\", \"Direct target genes not identified by ChIP\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showing that GLIS1 co-expression with OSK dramatically enhances iPSC reprogramming in both mouse and human fibroblasts revealed GLIS1 as a potent pluripotency-enabling factor, consistent with its enrichment in oocytes and zygotes.\",\n      \"evidence\": \"Retroviral transduction of GLIS1+OSK into fibroblasts, iPSC colony counting, DNA microarray, germline chimera formation\",\n      \"pmids\": [\"21654807\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of chromatin remodeling by GLIS1 during reprogramming unknown at this stage\", \"Direct versus indirect activation of Myc/Nanog/Wnt pathways unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Three contemporaneous studies expanded GLIS1's functional scope: cooperative chromatin opening in a 7-factor reprogramming system, regulation of mesenchymal lineage commitment via super-enhancers, and requirement for cardiac valve development in zebrafish, collectively establishing GLIS1 as a broadly acting chromatin and developmental regulator.\",\n      \"evidence\": \"7-factor reprogramming with ATAC-seq/RNA-seq dropout (MEFs); super-enhancer mapping plus overexpression in ST2 cells; morpholino knockdown in zebrafish with IHC in mouse embryonic heart\",\n      \"pmids\": [\"31216469\", \"30544251\", \"31112420\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Zebrafish morpholino phenotype not confirmed by genetic knockout\", \"Direct GLIS1 binding sites in mesenchymal or cardiac valve genes not mapped\", \"Relative contribution of GLIS1 versus other factors in 7F system unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"ChIP-seq and ATAC-seq demonstrated that GLIS1 directly binds and opens glycolytic gene chromatin while closing somatic loci, and metabolomic profiling showed the resulting metabolic shift feeds back via acetyl-CoA and lactate to install activating histone marks at pluripotency loci — resolving the mechanistic basis of GLIS1's reprogramming activity as an epigenome–metabolome–epigenome cascade.\",\n      \"evidence\": \"ATAC-seq, ChIP-seq, metabolomics, histone modification profiling during GLIS1-driven reprogramming\",\n      \"pmids\": [\"32839595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GLIS1 acts as a true pioneer factor (binds closed nucleosomal DNA) versus a facilitator of existing accessible sites not formally tested\", \"Structural basis of GLIS1–chromatin interaction unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of WNT5A as a direct transcriptional target mediating GLIS1-driven breast cancer motility, with GLIS1 itself induced by HIF-2α/AP-1 under hypoxia, placed GLIS1 in a hypoxia–Wnt signaling axis promoting cancer invasion; separately, miR-1-3p was confirmed to directly target GLIS1 mRNA, establishing post-transcriptional regulation.\",\n      \"evidence\": \"siRNA knockdown rescue of WNT5A, transcriptome analysis, luciferase reporter for miR-1-3p targeting of GLIS1 3′UTR, in vivo tumor assays\",\n      \"pmids\": [\"32047936\", \"33154575\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ChIP confirmation of GLIS1 binding at WNT5A promoter not shown\", \"Relevance to primary human tumors versus cell line systems uncertain\", \"Cooperation with CUX1 at Wnt loci (from 2014 study) not integrated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Genetic knockout of GLIS1 in mice caused progressive trabecular meshwork degeneration and chronically elevated intraocular pressure, while cistrome analysis identified ECM and glaucoma-associated genes as direct targets, providing definitive in vivo evidence for GLIS1 in intraocular pressure regulation and glaucoma pathogenesis.\",\n      \"evidence\": \"GLIS1 KO mice, MRI, histopathology, IOP measurement, transcriptome and ChIP-seq in trabecular meshwork\",\n      \"pmids\": [\"34385434\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Human genetic validation (GLIS1 mutations in glaucoma patients) not established\", \"Downstream effector mechanisms (specific ECM components) not functionally validated individually\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Three studies revealed new GLIS1 transcriptional programs in distinct cellular contexts: direct activation of SGK1–STAT3–PD1 axis driving CD8+ T cell exhaustion, interaction with PGC1-α maintaining mitochondrial quality control in aging kidneys, and direct activation of COMP/ITGA11 promoting cervical cancer EMT — demonstrating GLIS1 as a context-dependent transcriptional regulator of immunity, mitochondrial homeostasis, and tumor invasion.\",\n      \"evidence\": \"ChIP-seq/RNA-seq in CD8+ T cells with in vivo tumor models; co-IP of GLIS1–PGC1-α with siRNA and overexpression in kidney models; ChIP at COMP/ITGA11 promoters with siRNA rescue in cervical cancer cells\",\n      \"pmids\": [\"36787938\", \"37852548\", \"38157104\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"PGC1-α interaction domain on GLIS1 not mapped\", \"Whether GLIS1-driven T cell exhaustion is reversible therapeutically unknown\", \"Single-lab findings for each context await independent replication\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Two studies uncovered regulatory layers controlling GLIS1 function: GLIS1 physically interferes with KAT5 lactyltransferase–histone H3 interaction to suppress histone lactylation and cellular senescence, while METTL3/YTHDF1-mediated m6A modification of GLIS1 mRNA controls its translational efficiency in aging kidneys — establishing both a non-transcriptional effector mechanism and an epitranscriptomic input regulating GLIS1 protein levels.\",\n      \"evidence\": \"AlphaFold2/AutoDock prediction with co-IP validation and GLIS1 CKO/overexpression mouse models for KAT5; m6A-seq, RIP, ribosomal IP, luciferase reporters, and METTL3/YTHDF1 silencing for m6A regulation\",\n      \"pmids\": [\"39643036\", \"39736678\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GLIS1–KAT5 interaction relies on computational prediction without crystallographic validation\", \"Whether m6A regulation of GLIS1 operates beyond kidney tissue is unknown\", \"Single-lab findings for both mechanisms\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include whether GLIS1 functions as a bona fide pioneer factor capable of binding nucleosomal DNA, the structural basis of its interactions with chromatin and protein partners (PGC1-α, KAT5), whether GLIS1 variants contribute to human glaucoma or other Mendelian diseases, and how its diverse context-dependent transcriptional programs are specified.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural data for GLIS1 or its complexes\", \"Pioneer factor status not formally tested with nucleosome binding assays\", \"Human genetic studies linking GLIS1 mutations to disease are absent from the literature\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 7, 10, 11, 13]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 7, 10, 11, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 4, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0004839726\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2, 7, 10, 11]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [10, 13]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PGC1A\",\n      \"KAT5\",\n      \"CUX1\",\n      \"METTL3\",\n      \"YTHDF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}